Poster Session B

7:00 AM

Cancer Care Delivery System and Payment Reform

7:20 AM

Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer

J. Y. Lee¹, T. H. Kim¹, D. H. Suh², J. W. Kim¹, N. H. Park¹, Y. S. Song¹ and S. B. Kang³
¹Seoul National University, Seoul, South Korea, ²Seoul National University Bundang Hospital, Seong Nam, South Korea, ³Konkuk University School of Medicine, Seoul, South Korea

7:40 AM

344 - Poster Session B

Availability and scope of integrated screening for patients with Lynch syndrome

S. Pauk¹, D. Gerber², T. A. Caputo³ and M. K. Frey⁴
¹Weill Cornell Medical Center, New York, NY, ²New York Presbyterian Hospital - Weill Cornell Medical College, New York, NY, ³Weill Cornell Medical College, New York, NY, ⁴New York University School of Medicine, New York, NY

8:00 AM

345 - Poster Session B

Socioeconomic status and health insurance as predictors of access to high-volume hospital care for women with early-stage ovarian cancer

F. W. Liu¹, J. Chang², M. Hodeib¹, A. Ziogas², K. Penner¹, H. Anton-Culver³ and R. E. Bristow²
¹University of California at Irvine Medical Center, Orange, CA, ²University of California, Irvine, Irvine, CA, ³University of California at Irvine, Irvine, CA

8:20 AM

346 - Poster Session B

Cost comparison among robotic, laparoscopic, and laparoendoscopic single-site surgery in gynecologic oncology

J. M. Stephan, M. E. McDonald, J. Hansen, H. D. Reyes, A. Button and M. J. Goodheart
University of Iowa Hospitals and Clinics, Iowa City, IA

8:40 AM

347 - Poster Session B

Use of a perioperative anticoagulation protocol in gynecologic oncology patients receiving continuous epidural analgesia

E. Pelkofski¹, M. B. Courtney-Brooks², C. K. Tanner Kurtz¹, J. Rowlingson¹, M. Smolkin³ and L. Duska¹
¹University of Virginia Health System, Charlottesville, VA, ²Magee-Womens Hospital of UPMC, Pittsburgh, PA, ³University of Virginia, Charlottesville, VA

9:00 AM

348 - Poster Session B

Body mass index (BMI), postoperative complications, and perioperative resource utilization by hysterectomy approach for patients in a national cohort with endometrial cancer or complex atypical hyperplasia

J. A. Harris, L. A. Baldwin, R. W. Miller, F. R. Ueland, J. R. Vannagell and C. P. Desimone
University of Kentucky Medical Center, Lexington, KY

9:20 AM

349 - Poster Session B

Use of Lean and Six Sigma methodology to improve clinic efficiency in a high-volume tertiary care gynecologic oncology clinic

J. J. Mueller, H. Lothamer², E. Pelkofski², W. Novicoff³ and L. Duska²
¹University of Virginia Health System, Charlottesville, VA, ²University of Virginia, Charlottesville, VA

9:40 AM

350 - Poster Session B

An economic analysis of cisplatin alone versus cisplatin doublets in the treatment of women with advanced or recurrent cervical cancer

J. P. Geisler¹, A. Walter² and K. J. Manahan¹
¹University of Toledo College of Medicine and Life Sciences, Toledo, OH, ²The University of Oklahoma, Stephenson Cancer Center, Oklahoma City, OK

10:00 AM

351 - Poster Session B

Safety and cost savings of omitting cardiac surveillance during treatment with pegylated liposomal doxorubicin in gynecologic oncology survivors

C. L. Kushnir¹, A. Angarita¹, A. K. Sinno¹, S. D. Thompson¹, E. J. Tanner III¹, R. L. Giuntoli II¹, K. C. Long², A. A. Secord³ and A. Nickles Fader¹
¹Johns Hopkins Medical Institutions, Baltimore, MD, ²Memorial Sloan-Kettering Cancer Center, Brooklyn, NY, ³Duke University Medical Center, Durham, NC

10:20 AM

352 - Poster Session B

Cost-effectiveness analysis of treatment modalities for women with high-intermediate risk endometrial carcinoma: should Gynecologic Oncology Group (GOG) 249 have included a chemotherapy-only arm?

E. E. Landers, R. C. Arend, J. M. Straughn Jr. and C. A. Leath III
University of Alabama at Birmingham, Birmingham, AL

10:40 AM

353 - Poster Session B

A novel clinical trial recruitment strategy for women's cancers

B. J. Rimel, J. Lester, C. Dang, L. Sabacan, D. Park and B. Y. Karlan
Cedars-Sinai Medical Center, Los Angeles, CA

11:00 AM

354 - Poster Session B

Out with the old and in with the neoadjuvant: changes and influences in ovarian cancer practice patterns among Society of Gynecologic Oncology (SGO) members

E. R. King, R. L. Coleman, D. Urbauer, B. Fellman, A. K. Sood and A. M. Nick
The University of Texas MD Anderson Cancer Center, Houston, TX

11:20 AM

355 - Poster Session B

National Comprehensive Cancer Network (NCCN) guidelines for gynecologic malignancies: where's the beef?

C. L. Walters Haygood, J. Fauci, M. M. Shah and W. K. Huh
University of Alabama at Birmingham, Birmingham, AL

11:40 AM

356 - Poster Session B

Clinical utility and cost-effectiveness of preoperative CT in endometrial cancer patients

G. Bogani¹, S. C. Dowdy¹, B. S. Gostout¹, B. A. Cliby¹, J. Morris¹, F. Ghezzi², A. L. Weaver¹, J. N. Bakkum-Gamez¹, K. C. Podratz¹ and A. Mariani¹
¹Mayo Clinic, Rochester, MN, ²University of Insubria, Varese, Italy

12:00 PM

357 - Poster Session B

Improving outcomes in patients with suspected ovarian cancer: a quality improvement program

M. M. Shah, J. M. Estes, C. A. Leath III, R. D. Alvarez and J. M. Straughn Jr.
University of Alabama at Birmingham, Birmingham, AL

12:20 PM

358 - Poster Session B

Cost comparison between in hospital death and discharge to hospice among gynecologic cancer patients

M. A. Davis, K. K. Ward, N. R. Shah, L. M. Bean, C. C. Saenz, M. T. McHale and S. C. Plaxe
UCSD Rebecca and John Moores Cancer Center, La Jolla, CA

12:40 PM

359 - Poster Session B

Preoperative imaging of uterine malignancy

W. Baker, E. Pelkofski and L. Duska
University of Virginia Health System, Charlottesville, VA

1:00 PM

360 - Poster Session B

Fighting cancer together: shared medical appointments - a feasibility survey

L. S. Prescott, D. Quinn, C. C. L. Sun, P. T. Soliman, K. M. Schmeler, C. F. Levenback, J. Watkins, E. Garcia, D. Urbauer and D. C. Bodurka
The University of Texas MD Anderson Cancer Center, Houston, TX

1:20 PM

361 - Poster Session B

Breast cancer following ovarian cancer in BRCA mutation carriers: what is the cost of surveillance?

D. Y. Paik¹, F. Amersi¹, C. Bresee¹, C. Dang¹, B. Y. Karlan², A. J. Li¹, C. Walsh¹, B. J. Rimel¹, R. S. Leuchter¹ and I. Cass¹
¹Cedars-Sinai Medical Center, Los Angeles, CA, ²David Geffen School of Medicine at UCLA, Los Angeles, CA

1:40 PM

362 - Poster Session B

Robotic versus abdominal radical hysterectomy for early cervical cancer: a single-center experience

V. Zanagnolo¹, D. Rollo², T. Tomaselli³, L. Bocciolone¹, F. Landoni¹, G. Aletti¹ and A. Maggioni¹
¹European Institute of Oncology, Milan, Italy, ²European Institute of Oncology, milan, Italy, ³European Institute of Oncology, milano, Italy

2:00 PM

363 - Poster Session B

Trends in robotic surgery in uterine cancer: a nationwide study of 13,719 patients

J. K. Chan¹, K. W. Blansit¹, J. Fuh¹, T. N. Tsuei¹, L. M. Chen¹, R. A. Brooks¹, S. M. Ueda¹, X. Yu² and D. S. Kapp³
¹UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ²University of Memphis, Memphis, TN, ³Stanford University, Stanford, CA

2:20 PM

364 - Poster Session B

Is paclitaxel a more cost-effective choice for maintenance therapy than bevacizumab in the primary treatment of advanced ovarian cancer?

C. L. Kushnir¹, K. Frick², Z. Zhao² and R. L. Giuntoli II¹
¹Johns Hopkins Medical Institutions, Baltimore, MD, ²Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

2:40 PM

365 - Poster Session B

Multiple lines of chemotherapy in recurrent epithelial ovarian cancer, are more lines better? A decision analytic model

K. M. Esselen¹, J. Kim², A. Wright³ and N. S. Horowitz²
¹Brigham and Women's Hospital/Harvard University, Boston, MA, ²Harvard University, Boston, MA, ³Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA

3:00 PM

366 - Poster Session B

Is the survival advantage gained by the addition of bevacizumab to chemotherapy for the treatment of recurrent, persistent, or advanced cervical cancer worth the additional cost? A cost-effectiveness analysis

E. D. Schroeder¹, X. Burbano-Levy², J. De La Garza¹, A. E. Garcia-Soto³, K. E. Hew¹, F. Andrade¹, F. Simpkins⁴, J. M. Pearson⁵, J. A. Lucci III⁶ and J. P. Diaz⁷
¹University of Miami-Jackson Memorial Hospital, Miami, FL, ²Zilonis Health, Inc., Miami, FL, ³University of Miami Jackson Memorial Hospital, Miami, FL, ⁴University of Miami, Miami, FL, ⁵University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, ⁶University of Miami Miller School of Medicine, Miami, FL, ⁷South Miami Gynecologic Oncology Group, Miami, FL

3:20 PM

367 - Poster Session B

Analysis of patients referred to an academic gynecologic oncology clinic with an OVA1 test

K. N. Slaughter, R. Farrell, K. N. Moore and D. S. McMeekin
The University of Oklahoma, Oklahoma City, OK

3:40 PM

368 - Poster Session B

Risk of breast cancer following ovarian cancer and the impact on overall survival

D. Y. Paik¹, F. Amersi¹, C. Bresee¹, A. Gangi¹, B. Y. Karlan², A. J. Li¹, C. Walsh¹, B. J. Rimel¹, R. S. Leuchter¹ and I. Cass¹
¹Cedars-Sinai Medical Center, Los Angeles, CA, ²David Geffen School of Medicine at UCLA, Los Angeles, CA

4:00 PM

369 - Poster Session B

Outcomes of pelvic exenteration: does surgeon experience matter?

A. M. Nick, P. T. Ramirez, K. M. Schmeler, S. N. Westin, N. D. Fleming, M. Frumovitz, M. F. Munsell and P. T. Soliman
The University of Texas MD Anderson Cancer Center, Houston, TX

4:20 PM

370 - Poster Session B

Trends in the use of robotic surgery for the treatment of cervical cancer

N. R. Shah, K. K. Ward, M. A. Davis, L. M. Bean, C. C. Saenz, M. T. McHale and S. C. Plaxe
UCSD Rebecca and John Moores Cancer Center, La Jolla, CA

4:40 PM

371 - Poster Session B

An economic analysis of bevacizumab in treatment of cervical cancer

J. P. Geisler¹, A. Walter² and K. J. Manahan¹
¹University of Toledo College of Medicine and Life Sciences, Toledo, OH, ²The University of Oklahoma, Stephenson Cancer Center, Oklahoma City, OK

5:00 PM

372 - Poster Session B

Evaluation of a universal surgical risk calculator for quality improvement on a gynecologic oncology service

J. B. Szender, P. J. Frederick, S. N. Akers, S. B. Lele and K. O. Odunsi
Roswell Park Cancer Institute, Buffalo, NY

5:20 PM

373 - Poster Session B

Is pharmacologic prophylaxis indicated for prevention of thromboembolic disease after robotic and laparoscopic hysterectomy in a gynecologic oncology practice? Analysis of morbidity and cost in 1,335 cases

E. M. Salom¹ and M. A. Penalver²
¹Florida International University, Miami Springs, FL, ²Florida International University, Herbert Wertheim College of Medicine, Coral Gables, FL

5:40 PM

374 - Poster Session B

Cross-sectional study on the impact of a natural disaster on delivery of gynecologic oncology care

G. David-West, F. Musa, M. K. Frey, L. R. Boyd, B. Pothuri, J. P. Curtin and S. V. Blank
New York University School of Medicine, New York, NY

6:00 PM

375 - Poster Session B

Significant delay in the treatment of endometrial cancer based on race and insurance status

S. B. Dewdney¹, D. R. Dolly¹, A. Mihai¹, L. Fogg¹, A. Guirguis¹, E. L. Yordan² and J. Rotmensch¹
¹Rush University Medical Center, Chicago, IL, ²Rush University Medical Center, Riverwoods, IL

6:20 PM

376 - Poster Session B

Patterns of care of women with low-grade cervical cytologic abnormalities

R. Kupets¹ and L. Paszat²
¹Sunnybrook Cancer Center/University of Toronto, Toronto, ON, Canada, ²Institute of Clinical Evaluative Sciences, Toronto, ON, Canada

6:40 PM

Cancer in Vulnerable Populations: Obesity, Elderly and the Underserved

7:00 PM

377 - Poster Session B

Utilizing peer teen advocates and social media to increase human papillomavirus (HPV) vaccination awareness in urban settings

S. Tyree Francis¹, M. A. Kiepczynski,², S. Young³ and D. Uyar³
¹The Boys & Girls Clubs of Greater Milwaukee, Milwaukee, WI, ²The City of Milwaukee Health Department, Milwaukee, WI, ³Medical College of Wisconsin, Milwaukee, WI

7:20 PM

378 - Poster Session B

Type I uterine cancer in United States (US)-born vs immigrants: a study of 4,834 patients

E. J. Simons¹, K. W. Blansit¹, T. N. Tsuei¹, R. A. Brooks¹, S. M. Ueda¹, D. S. Kapp² and J. K. Chan¹
¹UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ²Stanford University, Stanford, CA

7:40 PM

379 - Poster Session B

The use of a geographic information system to identify advanced cervical cancer patients in California

G. Westhoff¹, K. W. Blansit¹, B. J. Monk², R. A. Brooks¹, S. M. Ueda¹, D. S. Kapp³ and J. K. Chan¹
¹UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ²University of Arizona Cancer Center, Phoenix, AZ, ³Stanford University, Stanford, CA

8:00 PM

380 - Poster Session B

Sarcopenia: preoperative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer

L. M. Kuroki¹, M. Mangano², J. Allsworth¹, C. Menias³, L. S. Massad¹, A. R. Hagemann¹, M. A. Powell¹, D. G. Mutch¹ and P. H. Thaker¹
¹Washington University School of Medicine, St. Louis, MO, ²Massachusetts General Hospital/Harvard Medical School, Boston, MA, ³Washington University School of Medicine, St.Louis, MO

8:20 PM

381 - Poster Session B

Human papillomavirus (HPV) genotype prevalence in invasive vaginal cancers from a registry-based United States population

A. K. Sinno^1,2, M. Saraiya³, T. Thompson³, B. Hernandez⁴, M. T. Goodman⁴, W. Cozen⁵, M. Steinau³, M. Watson³ and E. Unger³
¹Johns Hopkins Medical Institutions, Baltimore, MD, ²Emory University, Atlanta, GA, ³Centers for Disease Control and Prevention, Atlanta, GA, ⁴University of Hawaii Cancer Center, Honolulu, HI, ⁵Keck School of Medicine, LA, CA

8:40 PM

382 - Poster Session B

Body mass index and lymph node metastases in endometrial cancer: can we omit lymphadenectomy in the morbidly obese?

S. L. Yanke¹, M. M. K. Shahzad^1,2, R. J. Chappell¹ and D. M. Kushner¹
¹University of Wisconsin School of Medicine and Public Health, Madison, WI, ²H. Lee Moffitt Cancer Center, Tampa, FL

9:00 PM

383 - Poster Session B

Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer

M. Hodeib¹, R. E. Bristow², L. M. Randall², F. W. Liu², J. Chang¹, A. Ziogas¹ and H. Anton-Culver²
¹University of California at Irvine Medical Center, orange, CA, ²University of California at Irvine Medical Center, Orange, CA

9:20 PM

384 - Poster Session B

The increase in type I uterine cancer in 9,217 Hispanic women: a 20-year study

J. K. Chan¹, K. W. Blansit¹, T. N. Tsuei¹, R. A. Brooks¹, S. M. Ueda¹ and D. S. Kapp²
¹UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ²Stanford University, Stanford, CA

9:40 PM

385 - Poster Session B

Diabetes mellitus and ovarian cancer: more complex than increasing risk

M. M. Shah, B. K. Erickson, T. Matin, J. Y. Martin, L. R. Daily, D. N. Pasko, C. L. Walters Haygood, J. Fauci and C. A. Leath III
University of Alabama at Birmingham, Birmingham, AL

10:00 PM

386 - Poster Session B

Borderline ovarian tumor in the elderly: impact on recurrence and survival

T. Song¹, B. S. Yoon², Y. Y. Lee¹, C. H. Choi¹, T. J. Kim³, J. W. Lee³, D. S. Bae³ and B. G. Kim³
¹Samsung Medical Center, Seoul, South Korea, ²CHA Gangnam Medical Center, CHA University, Seoul, South Korea, ³Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

10:20 PM

387 - Poster Session B

Management and outcomes for elderly women with vulvar cancer over time

J. A. Rauh-Hain¹, J. T. Clemmer¹, R. M. Clark¹, L. S. Bradford², W. B. Growdon³, A. Goodman¹, D. M. Boruta II¹, D. S. Dizon¹, J. O. Schorge¹ and M. G. Del Carmen¹
¹Massachusetts General Hospital/Harvard University, Boston, MA, ²University of Massachusetts, Worcester, MA, ³Massachusetts General Hospital, Boston, MA

10:40 PM

388 - Poster Session B

CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity

Q. Zhang¹, R. E. Schmandt¹, J. Celestino¹, A. McCampbell¹, M. Yates¹, D. Urbauer¹, R. Broaddus¹, D. S. Loose², G. L. Shipley² and K. H. Lu¹
¹The University of Texas MD Anderson Cancer Center, Houston, TX, ²The University of Texas Medical School at Houston, Houston, TX

11:00 PM

389 - Poster Session B

Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis

G. Garg¹, C. Yee², K. Schwartz², R. T. Morris³, D. G. Mutch⁴ and M. A. Powell⁴
¹Washington University School of Medicine, Saint Louis, MO, ²Karmanos Cancer Institute, Detroit, MI, ³Wayne State University, Detroit, MI, ⁴Washington University School of Medicine, St. Louis, MO

11:20 PM

390 - Poster Session B

In a safety net population, human papillomavirus (HPV)4 vaccine adherence worsens as body mass index (BMI) increases

At the authors request, this submission has been withdrawn.

11:40 PM

391 - Poster Session B

Transversus abdominis plane block in patients undergoing robotic surgery for gynecologic cancers: A randomized controlled trial

B. T. Hotujec^1,2, M. J. Donnelly², S. L. Rose², A. N. Al-Niaimi², R. J. Chappell², S. L. Stewart², S. M. Bruggink^2,3 and D. M. Kushner²
¹Dean Clinic, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Mayo Clinic, Rochester, MN

12:00 AM

392 - Poster Session B

Impact of race, socioeconomic status, and the healthcare system on the treatment of advanced-stage ovarian cancer in California

B. J. Long¹, J. Chang², A. Ziogas², K. S. Tewari³, H. Anton-Culver³ and R. E. Bristow²
¹University of California at Irvine Medical Center, Orange, CA, ²University of California, Irvine, Irvine, CA, ³University of California at Irvine, Irvine, CA

12:20 AM

393 - Poster Session B

Risk of complications after robotic hysterectomy for endometrial cancer in obese patients with preoperative comorbidities

M. Rosen¹, M. I. Liang¹, G. A. L. McCann², A. Clements¹, D. E. Cohn¹, D. M. O'Malley¹, J. M. Fowler¹, R. Salani¹ and F. J. Backes¹
¹The Ohio State University, Columbus, OH, ²University of Texas Health Science Center at San Antonio, San Antonio, TX

12:40 AM

394 - Poster Session B

Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women

H. Mahdi¹, J. Hou², L. L. Kowk³, R. DeBernardo¹, M. Moslemi-Kebria¹ and C. Michener¹
¹Cleveland Clinic, Cleveland, OH, ²The Cleveland Clinic, Cleveland, OH, ³Case Western Reserve University, Cleveland, OH

1:00 AM

395 - Poster Session B

The impact of obesity on 30-day morbidity and mortality after surgery for endometrial cancer

H. Mahdi¹, A. M. Jernigan², C. Schlick³, R. DeBernardo¹ and M. Moslemi-Kebria¹
¹Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic Foundation, Cleveland, OH, ³The Cleveland Clinic, Cleveland, OH

1:20 AM

396 - Poster Session B

Levonorgestrel intrauterine device (IUD) treatment of complex atypical hyperplasia and grade 1 endometrioid endometrial cancer in postmenopausal women

W. Baker, E. Pelkofski and L. Duska
University of Virginia Health System, Charlottesville, VA

1:40 AM

397 - Poster Session B

Obesity and oncologic gynecologic surgery

L. Bresson¹, F. Narducci¹, C. Fournier², M. Le Carpentier³, C. Laculle², F. Le Tinier², A. Chevalier², D. Lefevre² and E. Leblanc¹
¹Centre Oscar Lambret, Lille, France, ²Oscar Lambret Center, Lille, France, ³Oscar Lambret Center, lille, France

2:00 AM

398 - Poster Session B

Perceptions of obesity and cancer risk in female bariatric surgery candidates: highlighting the need for physician action for unsuspectingly obese and high-risk patients

M. S. Henretta¹, A. R. Copeland², S. L. Kelley², P. T. Hallowell³ and S. C. Modesitt⁴
¹Stony Brook Medicine, Stony Brook, NY, ²University of Virginia, Charlottesville, VA, ³University of Virginia Health System, Charlotesville, VA, ⁴University of Virginia Health System, Charlottesville, VA

2:20 AM

399 - Poster Session B

Metformin use is associated with improved survival in women with endometrial cancer

L. A. Hahn, J. A. Villella, E. Chalas, K. C. Chan and E. A. Jimenez
Winthrop University Hospital, Mineola, NY

2:40 AM

400 - Poster Session B

Association between women's breast cancer incidence and smoking rates in Japan by graphical cohort analysis

K. Katayama¹, Y. Hirabayashi¹ and H. Y. Suketomo²
¹Kanagawa Cancer Center Institute, Yokohama, Japan, ²Japan Women's College of Physical Education, Tokyo, Japan

3:00 AM

401 - Poster Session B

Insulin receptor isoform expression in ovarian cancer in African American women

A. E. Wahner Hendrickson¹, R. Ali-Fehmi², M. L. Cote³, S. C. Harrington¹, M. S. Block¹, L. C. Hartmann¹, M. J. Maurer¹, K. R. Kalli¹ and P. Haluska Jr.¹
¹Mayo Clinic, Rochester, MN, ²Wayne State University, Detroit, MI, ³Karmanos Cancer Institute, Detroit, MI

3:20 AM

402 - Poster Session B

Bariatric surgery of a means to decrease mortality in women with type I endometrial cancer: an intriguing option in a population at risk for dying of complications of metabolic syndrome

R. Neff¹, D. E. Cohn¹, J. Chino², D. M. O'Malley¹ and L. J. Havrilesky²
¹The Ohio State University, Columbus, OH, ²Duke University Medical Center, Durham, NC

3:40 AM

403 - Poster Session B

A population-based comparison of human papillomavirus (HPV) distribution and cervical lesions in China

S. K. Goodrich¹, L. Li² and J. L. Belinson¹
¹The Cleveland Clinic Foundation, Cleveland, OH, ²Xinjiang Uygur Autonomous People’s Hospital, Xinjiang, China

4:00 AM

404 - Poster Session B

Prospective wound protocol to decrease the incidence of wound complications in obese gynecologic oncology patients

A. P. Novetsky¹, I. Zighelboim², S. R. Guntupalli³, Y. J. M. Ioffe¹, N. T. Kizer⁴, A. R. Hagemann¹, M. A. Powell¹, P. H. Thaker¹, D. G. Mutch¹ and L. S. Massad¹
¹Washington University School of Medicine, St. Louis, MO, ²St. Luke's Cancer Care Associates, Bethlehem, PA, ³University of Colorado Denver, Aurora, CO, ⁴Washington University School of Medicine, Maryville, IL

4:20 AM

405 - Poster Session B

Durable responses to sequential Megace in recurrent endometrial cancer

D. J. Wen¹, H. E. Godoy², L. M. Armao², T. J. McElrath², D. C. Kredentser², T. P. Morrissey² and P. F. Timmins III²
¹Albany Medical Center, Albany, NY, ²Women's Cancer Care Associates, Albany, NY

4:40 AM

406 - Poster Session B

Quantifying obesity-related increases in cost for the surgical management of uterine cancer

J. S. Kim¹, K. K. Ward², N. R. Shah², C. C. Saenz², M. T. McHale² and S. C. Plaxe²
¹Rebecca and John Moores UCSD Cancer Center, La Jolla, CA, ²UCSD Rebecca and John Moores Cancer Center, La Jolla, CA

5:00 AM

407 - Poster Session B

Barriers to cervical cancer screening in victims of intimate partner violence: a Gynecologic Oncology Fellows Research Network study

K. Levinson¹, A. M. Jernigan², S. Flocke³, A. I. Tergas^4,5, C. C. Gunderson⁶, W. K. Huh⁷, A. Nickles Fader⁸ and J. L. Belinson⁹
¹The Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic Foundation, Cleveland, OH, ³Case Western Reserve University, Cleveland, OH, ⁴Columbia University College of Physicians and Surgeons, New York, NY, ⁵Columbia University, New York, NY, ⁶The University of Oklahoma, Oklahoma City, OK, ⁷University of Alabama at Birmingham, Birmingham, AL, ⁸Johns Hopkins Medical Institutions, Baltimore, MD, ⁹Preventive Oncology International and Cleveland Clinic, Cleveland Heights, OH

5:20 AM

408 - Poster Session B

A prospective, randomized trial on the impact of patient navigation in women with abnormal cervical cytology

B. J. Tierney, M. Li, G. Young, D. E. Cohn and E. Paskett
The Ohio State University, Columbus, OH

5:40 AM

409 - Poster Session B

Black race independently predicts worse survival in uterine carcinosarcoma

B. K. Erickson¹, D. W. Doo², B. Zhang³, W. K. Huh¹ and C. A. Leath III¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Colorado Denver, Aurora, CO, ³Cincinnati Children's Hospital Medical Center, Cincinnati, OH

6:00 AM

410 - Poster Session B

Management of advanced epithelial ovarian cancer in the elderly

M. R. Davis¹, L. S. Bradford², R. M. Clark³, J. A. Rauh-Hain³, W. B. Growdon⁴, M. G. Del Carmen³ and J. O. Schorge³
¹Brigham and Women's Hospital/Harvard University, Boston, MA, ²University of Massachusetts, Worcester, MA, ³Massachusetts General Hospital/Harvard University, Boston, MA, ⁴Massachusetts General Hospital, Boston, MA

6:20 AM

411 - Poster Session B

Biguanides inhibit proliferation and decrease estrogen receptor expression in ovarian granulosa cell tumors

A. L. Jackson, J. E. Kilgore, H. Qiu, C. Zhou, P. A. Gehrig and V. L. Bae-Jump
University of North Carolina at Chapel Hill, Chapel Hill, NC

6:40 AM

412 - Poster Session B

A centrosome clustering suspect, HSET, is a potential biomarker for breast cancer aggressiveness in triple-negative breast cancer (TNBC) patients

G. Cantuaria¹, V. Pannu², S. Pawar², P. C. G. Rida², M. V. Gupta³ and R. Aneja²
¹Northside Hospital, Atlanta, GA, ²Georgia State University, Atlanta, GA, ³West Georgia Medical Center, LaGrange, GA

7:00 AM

413 - Poster Session B

Comparative surgical outcomes in endometrial cancer patients staged with robotics or laparotomy 65 years and older

M. S. Guy, B. R. Corr, M. A. Spillman, K. Behbakht, S. A. Davidson, J. Sheeder and S. R. Guntupalli
University of Colorado Denver, Aurora, CO

7:20 AM

414 - Poster Session B

Understanding barriers and facilitators to healthy lifestyle change in African American endometrial cancer survivors and their social network

N. K. Lee, S. Mistretta, S. Orzalli, S. Martins, M. Akinola and M. Gilliam
University of Chicago, Chicago, IL

7:40 AM

415 - Poster Session B

Body mass index (BMI) associations, including mismatch repair protein expression, in 1,051 endometrial carcinomas

A. S. Joehlin-Price¹, C. M. Perrino², J. Stephens¹, F. J. Backes¹, P. J. Goodfellow¹, D. E. Cohn¹ and A. Suarez¹
¹The Ohio State University, Columbus, OH, ²Washington University, St. Louis, MO

8:00 AM

416 - Poster Session B

Increasing minority participation in gynecologic oncology clinical trials through patient navigation

B. K. Erickson, R. D. Alvarez, C. A. Leath III, M. Fouad, A. Forero-Torez, S. Bae and E. E. Partridge
University of Alabama at Birmingham, Birmingham, AL

8:20 AM

417 - Poster Session B

Weight-based chemotherapy dosing does not increase chemotherapy-related toxicity in obese gynecologic cancer patients

J. Hansen, J. M. Stephan, M. Freesmeier, D. P. Bender, A. Button and M. J. Goodheart
University of Iowa Hospitals and Clinics, Iowa City, IA

8:40 AM

418 - Poster Session B

Minority participation in Gynecologic Oncology Group (GOG) studies

J. M. Scalici¹, M. A. Finan¹, J. Black¹, H. Lankes², W. E. Brady² and R. P. Rocconi¹
¹University of South Alabama, Mobile, AL, ²Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY

9:00 AM

419 - Poster Session B

Positive margins on cervical excision in a high-risk population: are our best practices good enough?

T. R. Buchanan Jr.¹, J. N. Rasner², M. L. Podolsky², R. K. Brannon², G. D. Alleyne² and S. D. Richard³
¹Drexel University College of Medicine, Philadelphia, PA, ²Drexel University College of Medicine, philadelphia, PA, ³Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, PA

9:20 AM

420 - Poster Session B

Geographic disparities in cancer care: is optimizing the distribution of the gynecologic oncology workforce the answer? A Gynecologic Oncology Fellows Research Network study

S. Ricci¹, A. I. Tergas^2,3, M. Gerardi Fairbairn⁴, K. N. Slaughter⁵, A. S. Bruegl⁶, E. Pelkofski⁷, R. Spencer⁸, R. E. Bristow⁹ and A. Nickles Fader¹
¹Johns Hopkins Medical Institutions, Baltimore, MD, ²Columbia University College of Physicians and Surgeons, New York, NY, ³Columbia University, New York, NY, ⁴Johns Hopkins Medical Institutions, Columbia, MD, ⁵The University of Oklahoma, Oklahoma City, OK, ⁶The University of Texas MD Anderson Cancer Center, Houston, TX, ⁷University of Virginia Health System, Charlottesville, VA, ⁸University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁹University of California, Irvine, Irvine, CA

9:40 AM

421 - Poster Session B

Elderly patients and customized narcotic dosing after gynecologic cancer surgery

R. Spencer, B. T. Hotujec, S. Uppal, R. J. Chappell, L. W. Rice, E. M. Hartenbach, S. L. Rose, A. N. Al-Niaimi, L. M. Barroilhet and D. M. Kushner
University of Wisconsin School of Medicine and Public Health, Madison, WI

10:00 AM

422 - Poster Session B

Contribution of human papillomavirus (HPV) genotypes to persistently abnormal cervical cytology in a high-risk Latino population

Y. A. Lyons, A. A. Kamat, M. R. Schwartz, D. R. Mody, H. Zhou, C. Hobday and Y. Ge
Houston Methodist Hospital, Houston, TX

10:20 AM

423 - Poster Session B

The characterization of morbidly obese ovarian cancer patients in the United States: a study of demographic and socioeconomic status

J. K. Chan¹, K. W. Blansit¹, T. N. Tsuei¹, R. A. Brooks¹, S. M. Ueda¹, X. Yu² and D. S. Kapp³
¹UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ²University of Memphis, Memphis, TN, ³Stanford University, Stanford, CA

10:40 AM

424 - Poster Session B

Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancer

A. M. Tran¹, B. J. Rimel¹, C. Walsh¹, I. Cass¹, B. Y. Karlan² and A. J. Li¹
¹Cedars-Sinai Medical Center, Los Angeles, CA, ²David Geffen School of Medicine at UCLA, Los Angeles, CA

11:00 AM

425 - Poster Session B

Weight loss in preparation for robotic-assisted surgery in the management of low-grade stage I uterine carcinoma: clinical outcomes

C. N. Jeppson, J. A. James, A. Gubbi, J. E. Kendrick IV, S. Ahmad and R. W. Holloway
Florida Hospital Cancer Institute, Orlando, FL

11:20 AM

426 - Poster Session B

The effect of age on completion of prescribed chemoradiation among patients with cervix cancer

L. Perry¹, C. C. Gunderson¹, A. Walter², S. Vesely¹, K. N. Moore¹ and A. Park³
¹The University of Oklahoma, Oklahoma City, OK, ²The University of Oklahoma, Stephenson Cancer Center, Oklahoma City, OK, ³The University of Oklahoma Health Sciences Center, Oklahoma City, OK

11:40 AM

427 - Poster Session B

Redefining the role of obesity, race and diabetes in Type I and Type II endometrial cancers: Potential targets for treatment beyond cancer itself

E. M. Ko¹, P. Walter², L. H. Clark³, A. L. Jackson³, C. Bolac², L. J. Havrilesky², A. A. Secord², D. T. Moore³, P. A. Gehrig³ and V. L. Bae-Jump⁴
¹University of Pennsylvania, Penn Medicine, Philadelphia, PA, ²Duke University Medical Center, Durham, NC, ³University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC

12:00 PM

428 - Poster Session B

The influence of obesity upon the survival of cervical cancer patients undergoing nonsurgical therapy

J. N. Casey¹, A. L. Jackson², J. E. Stine², D. T. Moore², A. C. Snavely², D. R. Roque², W. Z. Wysham³, L. Van Le², P. A. Gehrig⁴ and K. H. Kim²
¹University of North Carolina Hospitals, Chapel Hill, NC, ²University of North Carolina at Chapel Hill, Chapel Hill, NC, ³University of North Carolina at Chapel Hill, Hillsborough, NC, ⁴University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC

12:20 PM

429 - Poster Session B

Cervical cancer screening history in elderly patients in a rural population

R. Gogoi, A. L. Smith, H. Sun and J. D. Nash
Geisinger Medical Center, Danville, PA

12:40 PM

430 - Poster Session B

The use of metformin in obese women with endometrial cancer may reduce the risk of cancer recurrence: a retrospective review

A. F. Burnett¹, R. L. Stone¹ and C. Hall²
¹University of Arkansas for Medical Sciences, Little Rock, AR, ²University of Arkansas for Medical Sciences, little rock, AR

1:00 PM

431 - Poster Session B

Measurements of adiposity as predictive biomarkers for response to first-line bevacizumab-based chemotherapy in epithelial ovarian cancer (EOC)

K. N. Slaughter¹, T. Thai², S. Penaroza², D. M. Benbrook², E. Thavathiro², K. Ding¹, D. S. McMeekin¹ and K. N. Moore¹
¹The University of Oklahoma, Oklahoma City, OK, ²The University of Oklahoma Health Sciences Center, Oklahoma City, OK

1:20 PM

432 - Poster Session B

Impact of obesity on the survival of cervical cancer patients

A. L. Jackson¹, D. C. Orrey², J. N. Casey³, B. White³, D. T. Moore¹, A. C. Snavely¹, W. Z. Wysham⁴, D. R. Roque¹, J. E. Stine¹ and K. H. Kim¹
¹University of North Carolina at Chapel Hill, Chapel Hill, NC, ²University of North Carolina Medical School, Chapel Hill, NC, ³University of North Carolina Hospitals, Chapel Hill, NC, ⁴University of North Carolina at Chapel Hill, Hillsborough, NC

1:40 PM

433 - Poster Session B

Definitive therapy for clinical stage I endometrial cancer in the elderly: a National Cancer Database study

J. F. Lin¹, R. A. Laskey¹, J. Berger¹, J. T. Comerci¹, T. C. Krivak², M. B. Courtney-Brooks¹, M. Huang¹, J. L. Kelley III³, A. B. Olawaiye¹ and P. Sukumvanich¹
¹Magee-Womens Hospital of UPMC, Pittsburgh, PA, ²Western Pennsylvania Hospital, Pittsburgh, PA, ³University of Pittsburgh Medical Center, Pittsburgh, PA

2:00 PM

434 - Poster Session B

Obesity and operating room efficiency by phase of robotic surgery: results from a prospective trial in gynecologic oncology

R. Spencer, B. T. Hotujec, R. J. Chappell, S. L. Rose, A. N. Al-Niaimi and D. M. Kushner
University of Wisconsin School of Medicine and Public Health, Madison, WI

2:20 PM

435 - Poster Session B

Adherence to follow-up after treatment for high-grade dysplasia in underserved women

P. P. Jeudin¹, M. G. Del Carmen² and R. Perkins¹
¹Boston Medical Center, Boston, MA, ²Massachusetts General Hospital/Harvard University, Boston, MA

2:40 PM

436 - Poster Session B

Role of chemosensitization in elderly vaginal cancer patients: a National Cancer Data Base (NCDB) study

J. F. Lin¹, K. J. Hansen¹, R. A. Laskey¹, A. Binstock², S. Beriwal¹, M. Huang¹, T. C. Krivak³ and P. Sukumvanich¹
¹Magee-Womens Hospital of UPMC, Pittsburgh, PA, ²University of Pittsburgh Medical Center, Pittsburgh, PA, ³Western Pennsylvania Hospital, Pittsburgh, PA

3:00 PM

437 - Poster Session B

The impact of obesity on pathologic features and survival with endometrial cancer: a Gynecologic Oncology Group (GOG) LAP2 ancillary data study

C. C. Gunderson¹, J. Java², K. N. Moore¹ and J. L. Walker¹
¹The University of Oklahoma, Oklahoma City, OK, ²Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY

3:20 PM

438 - Poster Session B

Endometrial cancer complications and survival in morbidly obese African American and white women

S. M. Seward¹, M. L. Cote¹, Q. F. Ahmed², S. Bandyopadhyay², J. Ruterbusch², B. Alosh², E. Abdulfatah², R. T. Morris² and R. Ali-Fehmi²
¹Karmanos Cancer Institute, Detroit, MI, ²Wayne State University, Detroit, MI

3:40 PM

Clinical Trials in Gynecologic Cancers: Phase I, II, III and Trials in Progress

4:00 PM

439 - Poster Session B

Predicting everolimus/letrozole treatment efficacy in patients with advanced or recurrent endometrial cancer: a biomarker study

Y. Jiang¹, B. M. Slomovitz², Q. Zhang³, Y. Amin¹, R. Broaddus³, R. L. Coleman³ and K. H. Lu³
¹Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, ²Women's Cancer Center, Carol G Simon Cancer Center, Morristown, NJ, ³The University of Texas MD Anderson Cancer Center, Houston, TX

4:20 PM

440 - Poster Session B

Evaluation of slide storage and detection of molecular markers by immunohistochemistry (IHC) in formalin-fixed, paraffin embedded endometrial cancer tissues from a clinical trial: a GOG study

T. A. Grushko¹, V. L. Filiaci², A. G. Montag³, M. Apushkin³, M. J. Gomez¹, B. Marzullo², L. Monovich⁴, N. Ramirez⁴, M. J. Birrer⁵, O. I. Olopade¹ and G. Fleming⁶
¹The University of Chicago Medical Center, Chicago, IL, ²Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, ³Department of Pathology, The University of Chicago Medical Center, Chicago, IL, ⁴Gynecologic Oncology Group Tissue Bank, Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH, ⁵Massachusetts General Hospital Cancer Center/Harvard University, Boston, MA, ⁶University of Chicago Medical Center, Chicago, IL

4:40 PM

441 - Poster Session B

A Phase 0 study of dasatinib in endometrial cancer

L. Duska¹, H. Lothamer¹, W. Faust², G. Petroni³, P. M. Fracasso³ and S. Parsons³
¹University of Virginia Health System, Charlottesville, VA, ²University of Virgnia, Charlottesville, VA, ³University of Virginia, Charlottesville, VA

5:00 PM

442 - Poster Session B

Hyperthermic intraperitoneal chemotherapy (HIPEC) in gynecologic malignancies

M. Friedrich
HELIOS-Klinikum Krefeld, Krefeld, Germany

5:20 PM

443 - Poster Session B

Salvage therapy of intensively pretreated patients with epithelial ovarian cancer and other Mullerian tract carcinomas with treosulfan and gemcitabine

C. M. Kurbacher, S. Herz, G. Wessling, O. Horn, J. Lepique and J. A. Kurbacher
Gynecological Center Bonn-Friedensplatz, Bonn, Germany

5:40 PM

444 - Poster Session B

Prospective Phase II Trial of Adjuvant Pelvic Radiation “Sandwiched” Between Combination Paclitaxel/Carboplatin Chemotherapy in Women with Uterine Papillary Serous Carcinoma (UPSC)

M. Frimer¹, E. Girda¹, G. L. Goldberg¹, M. Klobocista¹, H. O. Smith¹, L. Reimers², K. Mehta¹, D. Smotkin¹, D. Y. S. Kuo¹ and M. H. Einstein¹
¹Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, ²Albert Einstein College of Medicine, Bronx, NY

6:00 PM

445 - Poster Session B

T cells prepared for adoptive transfer therapy have enhanced homing ability to ovarian cancer microenvironment

E. Zsiros, P. Duttagupta, T. Garrabrant, J. L. Tanyi, L. Kandalaft and G. Coukos
University of Pennsylvania, Philadelphia, PA

6:20 PM

446 - Poster Session B

Trial in Progress: A randomized double-blind phase 3 trial comparing vintafolide + pegylated liposomal doxorubicin (PLD) versus PLD + placebo in patients with platinum-resistant ovarian cancer (PROCEED)

R. W. Naumann¹, L. Gilbert², A. Habbe³, H. Ma³, S. Ghamande⁴ and I. B. Vergote⁵
¹Levine Cancer Institute, Charlotte, NC, ²McGill University Health Centre, Montreal, QC, Canada, ³Endocyte, Inc, West Lafayette, IN, ⁴Georgia Regents University, Augusta, GA, ⁵University Hospital Leuven, Leuven, Belgium

6:40 PM

447 - Poster Session B

Economic impact among family caregivers of advanced ovarian cancer patients

F. F. Plotti¹, C. Terranova¹, R. Montera², P. Damiani², A. Aloisi², S. Lopez², E. Montone³, A. Miranda² and R. Angioli¹
¹University Campus Bio-Medico of Rome, Rome, Italy, ²University Campus Bio Medico of Rome, Rome, Italy, ³University Campus Bio Medico of Rome, rome, Italy

7:00 PM

448 - Poster Session B

CA-125 as a response marker for vintafolide+pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer: the PRECEDENT trial

R. W. Naumann¹, M. Bidzinski², C. Lovejoy³, K. Anderson⁴, R. Rangwala⁵ and E. Kutarska⁶
¹Carolinas Medical Center, Charlotte, NC, ²Holycross Cancer Center, Kielce, Poland, ³Endocyte, Inc., West Lafayette, IN, ⁴Merck & Co., Inc., Whitehouse Station, NJ, ⁵Merck Research Laboratories, North Wales, PA, ⁶Centrum Onkologii Ziemi Lubelskiej, Lublin, Poland

7:20 PM

449 - Poster Session B

Adverse event profile by folate receptor status for vintafolide+pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer

T. J. Herzog¹, E. Kutarska², M. Bidzinski³, J. Symanowski⁴, B. Nguyen⁵, R. Rangwala⁶ and R. W. Naumann⁷
¹Columbia University & Herbert Irving Comprehensive Cancer Center, New York, NY, ²Centrum Onkologii Ziemi Lubelskiej, Lublin, Poland, ³Holycross Cancer Center, Kielce, Poland, ⁴Levine Cancer Institute, Charlotte, NC, ⁵Endocyte, Inc, West Lafayette, IN, ⁶Merck Research Laboratories, North Wales, PA, ⁷Carolinas Medical Center, Charlotte, NC

7:40 PM

450 - Poster Session B

Model prediction of mean PFS and OS time from a phase II trial comparing vintafolide plus pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer patients with 100% folate receptor–positive target

T. J. Herzog¹, K. Anderson², J. Wang² and R. Xu²
¹Columbia University & Herbert Irving Comprehensive Cancer Center, New York, NY, ²Merck & Co., Inc., Whitehouse Station, NJ

8:00 PM

451 - Poster Session B

Adoptive transfer of CD3/CD28 co-stimulated T cells improves clinical outcome in patient with recurrent ovarian cancer

J. L. Tanyi, E. Zsiros, D. Torigian, W. T. Hwang, M. A. Morgan, G. Coukos and L. Kandalaft
University of Pennsylvania, Philadelphia, PA

8:20 PM

452 - Poster Session B

Para-aortic lymph node(PAN)assessment and its surgical indication in patients with stage IB-IIA cervical cancer

X. Wu¹, J. Li¹ and Y. Zhou²
¹Fudan University Shanghai Cancer Center, Shanghai, China, ²Fudan University Shanghai Cancer Center, shanghai, China

8:40 PM

453 - Poster Session B

Laparoscopic treatment of early-stage ovarian cancer: surgical technique and outcome

M. E. Giavedoni¹, M. Perrotta², J. M. Saadi², R. Orti², R. Testa² and S. Gogorza²
¹Hospital Italiano de Buenos Aires, Argentina, Capital Federal, Argentina, ²Hospital Italiano de Buenos Aires, Capital Federal, Argentina

9:00 PM

Global Efforts to End Women’s Cancers

9:20 PM

454 - Poster Session B

Trends in the pathological diagnosis of serous fallopian tube, peritoneal, and ovarian cancer in the US

R. Ruskin¹, J. Rabban III¹, K. W. Blansit¹, R. A. Brooks¹, S. M. Ueda¹, D. S. Kapp² and J. K. Chan¹
¹UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ²Stanford University, Stanford, CA

9:40 PM

455 - Poster Session B

Polyphyllin D, a Chinese herb, potentiates cisplatin-induced death in ovarian cancer cell lines

E. Al Sawah¹, D. Marchion², Y. Xiong², F. Abbasi², I. Ramirez¹, S. H. Bush¹, N. Bou Zgheib¹, S. M. Apte², J. M. Lancaster² and P. L. Judson Lancaster²
¹University of South Florida College of Medicine, Tampa, FL, ²H. Lee Moffitt Cancer Center, Tampa, FL

10:00 PM

456 - Poster Session B

Epidemiologic characteristics of cervical cancer in Korean women

J. M. Lee¹ and K. D. Ki²
¹Kyung Hee University, Seoul, South Korea, ²Kyung Hee University Hospital at Gangdong, Seoul, South Korea

10:20 PM

457 - Poster Session B

The malignant potential of endometrial polyps can be determined by incorporating the Endometrial Intraepithelial Neoplasia (EIN) classification

Y. Naaman
The Hebrew University, Jerusalem, Israel, Jerusalem, Israel

10:40 PM

458 - Poster Session B

Conjugation to SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer

G. Garg¹, S. Vangveravong², C. Zeng³, M. A. Powell², D. G. Mutch², D. Piwnica-worms⁴, R. H. Mach³, D. Spitzer² and W. Hawkins²
¹Washington University School of Medicine, Saint Louis, MO, ²Washington University School of Medicine, St. Louis, MO, ³University of Pennsylvania, Philadelphia, PA, ⁴The University of Texas M.D. Anderson Cancer Center, Houston, TX

11:00 PM

459 - Poster Session B

Quantitative Assessment Of Immunofluorescence-based Biomarkers In Ovarian Cancer With Respect To Clinical Outcome

L. D. Nguyen¹, J. S. Cardenas-Goicoechea¹, D. A. Fishman², T. Kalir² and M. Donovan¹
¹Mount Sinai Medical Center, New York, NY, ²Mount Sinai School of Medicine, New York, NY

11:20 PM

460 - Poster Session B

Antisense oligonucleotide suppression of human IGF-1R inhibits the growth and survival of epithelial ovarian cancer cells

J. Tang¹, J. Li¹, G. Zeng², Y. Tang¹ and W. Tian¹
¹Hunan Provincial Tumor Hospital, Changsha, China, ²Nanhua Medical College, Hengyang, China

11:40 PM

461 - Poster Session B

The distribution of high-risk human papillomavirus genotype in high-grade cervical intraepithelial neoplasia of Korean women

M. H. Baek¹, W. S. Han¹, S. W. Lee¹, J. Y. Park², D. Kim², D. S. Suh², J. H. Kim², Y. M. Kim², Y. T. Kim² and J. H. Nam²
¹Dept. of OB/GYN, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ²University of Ulsan College of Medicine, ASAN Medical Center, Seoul, South Korea

12:00 AM

462 - Poster Session B

Comparative study results of conventional cytology, cervical colposcopy and histopathology obtained by LEEP

J. F. Francisco¹ and P. Roncato²
¹FACULDADE EVANGELICA DO PARANA, CURITIBA, PR, Brazil, ²FACULDADE EVANGELICA DE MEDICINA DO PARANA, CURITIBA, Brazil

12:20 AM

463 - Poster Session B

Secondary primary cancer after cervical cancer

M. C. Lim¹, S. S. Seo¹, S. Kang² and S. Y. Park¹
¹National Cancer Center, Goyang-si, South Korea, ²National Cancer Center, Ilsan, South Korea

12:40 AM

464 - Poster Session B

STAT1 pathway promotes progression of serous papillary endometrial cancer

T. Baba, B. Kharma, N. Matsumura, K. Yamaguchi, J. Hamanishi, K. Abiko and I. Konishi
Kyoto University, Kyoto, Japan

1:00 AM

465 - Poster Session B

Residual diseases after conization of women with stage IA-IB1 cervical carcinoma in region with high incidence

U. Chatchotikawong¹ and I. Ruengkhachorn²
¹Gynecologic Oncology Division,, Bangkoknoi, Thailand, ²Gynecologic Oncology Division, Bangkoknoi, Thailand

1:20 AM

466 - Poster Session B

A metabolomic approach to identifying platinum resistance in ovarian cancer

R. Rattan, L. Poisson, I. Datta, C. Tebbe, S. Dar, S. Hensley Alford, T. E. Buekers, S. Giri and A. R. Munkarah
Henry Ford Health System, Detroit, MI

1:40 AM

467 - Poster Session B

The inhibitory effects of metformin on ovarian cancer growth mimic those seen with caloric restriction

Z. Al-Wahab¹, C. Tebbe², J. Chhina², R. T. Morris¹, S. Giri², A. R. Munkarah² and R. Rattan²
¹Wayne State University, Detroit, MI, ²Henry Ford Health System, Detroit, MI

2:00 AM

468 - Poster Session B

Effect of dietary modulation on Ovarian Cancer progression and metastasis

Z. Al-Wahab¹, C. Tebbe², J. Chhina², R. T. Morris¹, S. Giri², R. Rattan² and A. R. Munkarah²
¹Wayne State University, Detroit, MI, ²Henry Ford Health System, Detroit, MI

2:20 AM

469 - Poster Session B

Metformin use is associated with earlier stage at diagnosis in ovarian cancer patients

Z. Al-Wahab¹, S. Hensley Alford², Y. Wang², N. Gill¹, J. L. Peters¹, S. Elshatanoufy¹, R. Ali-Fehmi¹, R. Rattan², R. T. Morris¹ and A. R. Munkarah²
¹Wayne State University, Detroit, MI, ²Henry Ford Health System, Detroit, MI

2:40 AM

470 - Poster Session B

Ovarian high grade serous cancer xenografts as pre-clinical models of response to chemotherapy

P. Cybulska^1,2, J. M. Stewart², B. A. Clarke², B. G. Neel³ and M. Q. Bernardini⁴
¹Institute of Medical Science, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada, ⁴Princess Margaret Hospital, Toronto, ON, Canada

3:00 AM

471 - Poster Session B

Practice intentions: cervical cancer screening among HPV vaccinated women

N. Nair¹, Z. Berkowitz² and M. Saraiya²
¹Emory University, Atlanta, GA, ²Centers for Disease Control and Prevention, Atlanta, GA

3:20 AM

472 - Poster Session B

Treatment of low-risk GTN with biweekly actinomycin-D

C. J. M. Reade¹, U. Habiba¹, L. R. Eiriksson², M. Cesari¹ and R. J. Osborne¹
¹University of Toronto, Toronto, ON, Canada, ²Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada

3:40 AM

473 - Poster Session B

Which strategy for the gynaecological screening in Lynch syndrome? A retrospective comparison of clinical examination, transvaginal ultrasound, and diagnostic hysteroscopy

At the authors request, this submission has been withdrawn.

4:00 AM

474 - Poster Session B

Cervical intraeptihelial neoplasia 3+ (CIN3+) is not the right endpoint for evaluating screening algorithms, as it does not reflect cancer risk accurately

W. K. Kinney¹, B. Fetterman², N. Poitras² and T. Lorey²
¹The Permanente Medical Group, Sacramento, CA, ²The Permanente Medical Group, Berkeley, CA

4:20 AM

475 - Poster Session B

Triage of HPV positive women with low grade aquamous epithelial lesion (LSIL) cytology by p16/Ki-67

W. K. Kinney¹, B. Fetterman², P. E. Castle³, M. Schiffman⁴, N. Poitras², S. Wood⁴, T. Lorey² and N. Wentzensen⁵
¹The Permanente Medical Group, Sacramento, CA, ²The Permanente Medical Group, Berkeley, CA, ³Albert Einstein College of Medicine, New York, NY, ⁴NCI, Bethesda, MD, ⁵National Cancer Institute, Bethesda, MD

4:40 AM

476 - Poster Session B

Development of serum multimarker assay for the differentiation diagnosis of ovarian cancer in patients with ovarian tumor

S. W. Lee¹, Y. M. Kim¹, M. S. Kyung², H. J. Song³, S. W. Kong⁴, D. Kim¹, J. H. Kim¹, Y. T. Kim¹ and J. H. Nam¹
¹University of Ulsan College of Medicine, ASAN Medical Center, Seoul, South Korea, ²University of Hallym, Dongtan Sacred Heart Hospital, Hwaseong, South Korea, ³Hallym University, Chuncheon, South Korea, ⁴Boston Children's Hospital, Boston, MA

5:00 AM

477 - Poster Session B

Analysis and comparison of somatic mutations between primary and recurrent ovarian carcinomas: a study in serial samples

Y. M. Kim¹, S. W. Lee¹, S. M. Chun¹, K. R. Kim¹, Y. T. Kim¹, J. H. Nam¹, P. V. Hummelen², L. MacConaill², W. C. Hahn² and S. J. Jang¹
¹University of Ulsan College of Medicine, ASAN Medical Center, Seoul, South Korea, ²Dana-Farber Cancer Institute, Boston, MA

5:20 AM

478 - Poster Session B

Primary care providers' knowledge of Hereditary Breast and Ovarian Cancer (HBOC) syndrome

N. Nair^1,2, C. Bellcross¹ and D. Meaney-Delman¹
¹Emory University, Atlanta, GA, ²Society of Gynecologic Oncology, Chicago, IL

5:40 AM

479 - Poster Session B

Preclinical assessment of donor PBMCs in a humanized mouse model of ovarian cancer

D. A. Altomare¹, V. Pandey¹, J. Oyer¹, S. B. Ingersoll² and A. J. Copik¹
¹University of Central Florida, Orlando, FL, ²Florida Hospital Cancer Institute, Orlando, FL

6:00 AM

480 - Poster Session B

Forgotten appointments equals missed opportunities: exploring the reasons for low HPV vaccine series completion rates

B. Brimmage¹, M. P. Gomez², S. Robazetti², M. S. Barratt², J. L. Dalrymple², A. Gregg² and L. A. Meyer³
¹University of North Carolina at Chapel Hill, Chapel Hill, NC, ²The University of Texas Medical School at Houston, Houston, TX, ³The University of Texas MD Anderson Cancer Center, Houston, TX

6:20 AM

481 - Poster Session B

Can the need for adjuvant radiotherapy be predicted preoperatively in patients with early-stage cervical cancer?

I. Ruengkhachorn
Gynecologic Oncology Division, Bangkoknoi, Thailand

6:40 AM

482 - Poster Session B

In vitro and in vivo evaluation of active hexose correlated compound (AHCC) for the eradication of HPV

J. A. Smith^1,2, L. M. Mathew¹, A. G. Gaikwad¹, J. P. Faro³, L. A. Meyer² and J. L. Dalrymple³
¹UT M.D. Anderson Cancer Center, Houston, TX, ²The University of Texas MD Anderson Cancer Center, Houston, TX, ³UT Health- University of Texas Medical School at Houston, Houston, TX

7:00 AM

483 - Poster Session B

The clinical relevance of a chemo response assay for treatment of epithelial ovarian cancer

A. Guirguis¹, D. R. Dolly¹, S. B. Dewdney¹, J. Rotmensch¹, P. Bitterman² and A. Barua¹
¹Rush University Medical Center, Chicago, IL, ²Rush University, Chicago, IL

7:20 AM

484 - Poster Session B

Disparity of cervical cancer care delivery in low-middle income countries

L. T. Chuang¹, S. S. Tedjarati², F. V. Price³ and W. T. Creasman⁴
¹Icahn School of Medicine at Mount Sinai, New York, NY, ²Westchester Medical Center, Valhalla, NY, ³West Penn Allegheny Health System, Pittsburgh, PA, ⁴Medical University of South Carolina, Charleston, SC

7:40 AM

Gestational Trophoblastic Disease/Vulvar & Vaginal Cancers/Rare Tumors/Sarcomas

8:00 AM

485 - Poster Session B

Type I interferons modulate methotrexate resistance in gestational trophoblastic neoplasia

K. M. Elias^1,2, K. Hasselblatt¹, S. W. Ng³ and R. S. Berkowitz⁴
¹Brigham and Women's Hospital, Boston, MA, ²Dana-Farber Cancer Institute, Boston, MA, ³Brigham & Women's Hospital, Boston, MA, ⁴Brigham and Women's Hospital/Harvard University, Boston, MA

8:20 AM

486 - Poster Session B

Comparative costs of first-line chemotherapy for gestational trophoblastic neoplasia: a second look

E. M. Ko¹, J. T. Soper² and E. R. Myers^3,4
¹University of Pennsylvania, Penn Medicine, Philadelphia, PA, ²University of North Carolina at Chapel HIll, Chapel Hill, NC, ³Duke University, Durham, NC, ⁴University of North Carolina Gillings School of Public Health, Chapel Hill, NC

8:40 AM

487 - Poster Session B

Risk factors for recurrent high grade vaginal intraepithelial neoplasia and progression to carcinoma

J. G. Cohen¹, S. Mehta¹, B. J. Rimel¹, C. Walsh¹, A. J. Li¹, B. Y. Karlan² and I. Cass¹
¹Cedars-Sinai Medical Center, Los Angeles, CA, ²David Geffen School of Medicine at UCLA, Los Angeles, CA

9:00 AM

488 - Poster Session B

Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: results from a population-based analysis

L. T. Gien^1,2, R. Sutradhar¹, G. M. Thomas², A. L. Covens³, L. M. Elit⁴, E. Rakovitch^1,2, A. Fyles⁵, M. Khalifa³ and L. Barbera^1,2
¹Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ²Sunnybrook Odette Cancer Center, Toronto, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴Juravinski Cancer Centre, Hamilton, ON, Canada, ⁵Princess Margaret Hospital, Toronto, ON, Canada

9:20 AM

489 - Poster Session B

Frequency of missing data from vulvar carcinoma pathology reports: results from a population-based cohort

L. Barbera^1,2, L. T. Gien², R. Sutradhar¹, G. M. Thomas², A. L. Covens³, L. M. Elit⁴, A. Fyles⁵, E. Rakovitch¹ and M. Khalifa³
¹Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ²Sunnybrook Odette Cancer Center, Toronto, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴Juravinski Cancer Centre, Hamilton, ON, Canada, ⁵Princess Margaret Hospital, Toronto, ON, Canada

9:40 AM

490 - Poster Session B

The impact of concurrent chemoradiation on survival compared to adjuvant radiation therapy alone in patients with node-positive vulvar cancer

R. A. Laskey¹, J. F. Lin¹, S. Beriwal¹, T. C. Krivak², M. S. Ross¹, J. T. Comerci¹, M. Huang¹, J. L. Kelley III¹, A. B. Olawaiye¹ and P. Sukumvanich¹
¹Magee-Womens Hospital of UPMC, Pittsburgh, PA, ²Western Pennsylvania Hospital, Pittsburgh, PA

10:00 AM

Surgical Techniques/Robotics/Minimally Invasive Surgery

10:20 AM

491 - Poster Session B

Outpatient laparoscopic radical hysterectomy

R. Pareja¹, G. J. Rendón¹, L. M. Echeverri¹, F. E. Echeverri² and P. T. Ramirez³
¹Instituto de Cancerología - Las Américas, Medellín, Colombia, ²Clínica Las Américas, Medellín, Colombia, ³The University of Texas MD Anderson Cancer Center, Houston, TX

10:40 AM

492 - Poster Session B

A randomized controlled trial of a proficiency-based, virtual-reality robotic simulation curriculum to teach robotic suturing

D. J. Kiely^1,2, W. H. Gotlieb³, S. Lau³, X. Zeng¹, V. Samouelian², H. Zakrzewski⁴, S. A. Fraser⁵, P. Korsieporn⁶, L. Drudi⁷ and J. Z. Press^1,8
¹Dept. Gyn Onc, McGill University - Jewish General Hospital, Montreal, QC, Canada, ²Université de Montréal - Hopital Notre Dame, Montreal, QC, Canada, ³McGill University - Jewish General Hospital, Montreal, QC, Canada, ⁴Dept Surgical Research, McGill University, Montreal, QC, Canada, ⁵Dept. General Surgery, McGill University - Jewish General Hospital, Montreal, QC, Canada, ⁶Dept. Obstetrics and Gynecology, McGill University, Montreal, QC, Canada, ⁷Dept Vascular Surgery, McGill University, Montreal, QC, Canada, ⁸Pacific Gynecology Specialists, Seattle, WA

11:00 AM

493 - Poster Session B

Does removal of a positive sentinel node without lymphadenectomy impact pelvic sidewall control in endometrial cancer?

G. Hofstetter¹, K. Alektiar², M. M. Leitao¹, M. L. Hensley¹, R. A. Soslow², O. Zivanovic², R. R. Barakat² and N. R. Abu-Rustum²
¹Memorial Sloan-Kettering Cancer Center, New York, NY, ²Memorial Sloan Kettering Cancer Center, New York, NY

11:20 AM

494 - Poster Session B

Laparoscopy versus robotics in the surgical management of endometrial cancer: comparison of histological findings and oncological outcomes

At the authors request, this submission has been withdrawn.

11:40 AM

495 - Poster Session B

Extraperitoneal para-aortic lymphadenectomy by robot-assisted laparoscopy in gynecologic oncology: the learning curve

F. Narducci
Centre Oscar Lambret, Lille, France

12:00 PM

496 - Poster Session B

Ultrasound Guided Subcostal Transversus Abdominis Plane (TAP) Infiltration with Liposomal Bupivacaine for Patients Undergoing Robotic Assisted Hysterectomy: A Retrospective Cohort Study

J. Hutchins, L. S. Downs, R. Ghebre, A. McNally, M. A. Geller and E. Gryzmala
University of Minnesota, Minneapolis, MN

12:20 PM

497 - Poster Session B

Postoperative pain scores and narcotic use in robotic-assisted versus laparoscopic hysterectomy for endometrial cancer

T. B. Turner¹, A. S. Habib¹, G. Broadwater¹, F. A. Valea¹, N. D. Fleming² and L. J. Havrilesky¹
¹Duke University Medical Center, Durham, NC, ²The University of Texas MD Anderson Cancer Center, Houston, TX

12:40 PM

498 - Poster Session B

Does minimally invasive surgery compromise the oncologic outcome of women with high-risk non-endometrioid endometrial carcinomas

J. A. Ducie¹, N. R. Abu-Rustum¹, D. S. Chi², G. J. Gardner¹, C. L. Brown¹, R. R. Barakat², E. Jewell¹, D. A. Levine¹ and M. M. Leitao¹
¹Memorial Sloan Kettering Cancer Center, New York, NY, ²Memorial Sloan-Kettering Cancer Center, New York, NY

1:00 PM

499 - Poster Session B

Hemostatic gelatin-thrombin matrix is associated with pelvic abscesses in patients undergoing surgery for gynecologic cancer

C. K. Anderson¹, K. Behbakht², M. A. Spillman², S. A. Davidson², E. E. Medlin³, A. Fontenot¹, J. Sheeder² and S. R. Guntupalli²
¹University of Colorado School of Medicine, Aurora, CO, ²University of Colorado Denver, Aurora, CO, ³University of Wisconsin Hospital, Madison, WI

1:20 PM

500 - Poster Session B

Robotic surgery 6-year analysis of annual peri-operative outcomes for patients with endometrial cancer

R. W. Holloway, G. E. Bigsby IV, G. B. Ghurani, J. E. Kendrick IV, J. A. James, C. N. Jeppson, A. Gubbi, N. M. Stavitzski and S. Ahmad
Florida Hospital Cancer Institute, Orlando, FL

1:40 PM

501 - Poster Session B

Incidence of port site hernias in robotic and laparoscopy assisted procedures in gynecologic oncology

E. M. Salom¹ and L. E. Mendez²
¹Florida International University, Miami Springs, FL, ²South Florida Gynecologic Oncology, Coral Gables, FL

2:00 PM

502 - Poster Session B

Do the skills of a gynecologic oncologist cross species?

S. K. Allensworth¹, D. Boon² and M. A. Spillman¹
¹University of Colorado Denver, Aurora, CO, ²Denver Zoo, Denver, CO

2:20 PM

503 - Poster Session B

Comparison of Peri-operative Outcomes and Complication Rates Between Conventional Versus Robotic-assisted Laparoscopy in the Evaluation and Management of Early, Advanced Stage and Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

F. R. Nezhat¹, T. N. Kolev², P. Vetere³, A. R. Radjabi⁴, L. Averbuch⁵, M. Vega⁶, S. Khalil⁷ and S. K. Altinbas⁸
¹State University of New York, College of Medicine @ StonyBrook, Mineola, NY, ²Lenox Hill Hospital, New York, NY, ³Winthrop University Hospital, New York, NY, ⁴New York Downtown, New York, NY, ⁵Lenox Hill Hospital, 10065, NY, ⁶St Lukes Roosevelt Hospital, New York, NY, ⁷St Lukes Roosevelt, New York, NY, ⁸Etlik Zubeyde Hanim Women’s Health Training and Research Hospital, Ankara, Turkey

2:40 PM

Survivorship and Supportive Care

3:00 PM

504 - Poster Session B

Breaking Bad News In Gynecologic Oncology: A National Fellows' Assessment Pilot Study

Y. Yvonne O'Meara¹, R. M. McVey², B. Hannon¹, M. Lourdias², K. Miller¹, G. Rodin^1,3 and A. L. Covens²
¹Princess Margaret Hospital, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Ontario Cancer Institute, Toronto, ON, Canada

3:20 PM

505 - Poster Session B

Understanding patient learning styles in gynecologic oncology: A Pilot Study

E. Pelkofski¹, M. Pardo², M. Smolkin³ and L. A. Cantrell¹
¹University of Virginia Health System, Charlottesville, VA, ²University of Virginia School of Medicine, Charlottesville, VA, ³University of Virginia, Charlottesville, VA

3:40 PM

506 - Poster Session B

Aggressive surgical debulking at time of primary and interval surgery at referral oncologic center: surgical and oncological outcomes

L. Minig^1,2, N. Colombo², V. Zanagnolo², G. Aletti², F. Landoni², L. Bocciolone², A. L. Garbi², A. Festi², M. Cárdenas-Rebollo³ and A. Maggioni²
¹HM Hospitales, Madrid, Spain, ²European Institute of Oncology, Milan, Italy, ³CEU San Pablo University, Madrid, Spain., Madrid, Spain

4:00 PM

507 - Poster Session B

A low carbohydrate nutritional program improves weight, insulin, and estrogenic parameters in obese patients with estrogen receptor positive endometrial cancer

L. A. Rojas-Espaillat^1,2,3, A. K. Krie¹, Z. M. Weber^4,5, K. N. Bohlen^1,2,3, Y. Hu^3,4, M. S. Fagerness^1,2, N. L. Flier^1,2, J. Kittelsrud^1,2, G. E. Davies^3,4 and E. A. Ehli^3,4
¹Avera Cancer Institute, Sioux Falls, SD, ²Avera Research Institute, Sioux Falls, SD, ³University of South Dakota, Sioux Falls, SD, ⁴Avera Institute for Human Genetics, Sioux Falls, SD, ⁵University of South Dakota, Vermillion, SD

4:20 PM

508 - Poster Session B

Prognostic factors associated with long-term survival in ovarian cancer

R. Cress¹, C. Morris², Y. Chen¹ and G. S. Leiserowitz³
¹UC Davis School of Medicine, Davis, CA, ²UC Davis Health System, Sacramento, CA, ³UC Davis Comprehensive Cancer Center, Sacramento, CA

4:40 PM

509 - Poster Session B

Clinical analysis of 13 cases of vulvar Pagets disease

E. Shrestha
Patan Hospital, Kathmandu, Nepal

5:00 PM

510 - Poster Session B

A survey of female cancer patients awareness of and preferences for receiving sexual health interventions

C. Stabile¹, E. C. Zabor², R. E. Baser¹, S. Goldfarb¹, D. J. Goldfrank¹, M. N. Dickler², N. R. Abu-Rustum¹, R. R. Barakat² and J. Carter¹
¹Memorial Sloan Kettering Cancer Center, New York, NY, ²Memorial Sloan-Kettering Cancer Center, New York, NY

5:20 PM

511 - Poster Session B

The impact of outpatient versus inpatient referrals to hospice

J. E. Stine¹, K. M. Doll², D. T. Moore¹, A. C. Snavely¹, L. Van Le¹, J. T. Soper³, D. Clarke-Pearson³, V. L. Bae-Jump¹, P. A. Gehrig¹ and K. H. Kim¹
¹University of North Carolina at Chapel Hill, Chapel Hill, NC, ²University of North Carolina at Chapel Hill, Chapel Hill, NC, Chapel Hill, NC, ³University of North Carolina at Chapel HIll, Chapel Hill, NC

5:40 PM

512 - Poster Session B

Symptoms burden in subjects with cervical cancer and supportive care: preliminary result from a developing country

A. T. Olagunju¹, O. F. Aina², F. O. Sarimiye³ and T. O. Olagunju⁴
¹College of Medicine, University of Lagos and Lagos University Teaching Hospital, Lagos, Nigeria, ²College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria, ³University College Hospital, Ibadan, Nigeria, ⁴Health Service Commission, Lagos, Nigeria

6:00 PM

513 - Poster Session B

Chemotherapy is a reasonable option for adjuvant therapy in the treatment of high-intermediate risk endometrial cancer

N. A. Nguyen, J. D. Boone, R. C. Arend, B. K. Erickson, B. Smith, H. Machemehi, M. Straughn, C. A. Leath III and K. S. Bevis
University of Alabama at Birmingham, Birmingham, AL

6:20 PM

514 - Poster Session B

A low carbohydrate nutritional program improves adiposity, metabolic, and nutritional parameters in obese patients with estrogen receptor positive endometrial and breast cancer

L. A. Rojas-Espaillat^1,2,3, A. K. Krie², Z. M. Weber^4,5, K. N. Bohlen^1,2,3, Y. Hu^3,4, M. S. Fagerness^1,2, J. Kittelsrud¹, N. L. Flier^1,2, G. E. Davies^3,4 and E. A. Ehli^3,4
¹Avera Research Institute, Sioux Falls, SD, ²Avera Cancer Institute, Sioux Falls, SD, ³University of South Dakota, Sioux Falls, SD, ⁴Avera Institute for Human Genetics, Sioux Falls, SD, ⁵University of South Dakota, Vermillion, SD

6:40 PM

515 - Poster Session B

National trends in the place of death and the impact of unscheduled admissions in patients with gynaecological cancer in England

S. Kaushik^1,2, L. Hounsome², C. Blinman¹, S. Glew³, R. Gornall¹ and J. Verne²
¹Cheltenham General Hospital, Cheltenham, United Kingdom, ²Public Health England Knowledge and Intelligence Team (South West), Bristol, United Kingdom, ³St Michael's Hospital, Bristol, United Kingdom

7:00 PM

516 - Poster Session B

Outpatient rapid desensitization for gynecologic oncology patients with mild to moderate hypersensitivity reactions to platinums

Q. Li¹, A. Waller², D. E. Cohn³ and D. M. O'Malley⁴
¹The Ohio State University, James Cancer Hospital, Columbus, OH, ²The Ohio State University, College of Pharmacy, Columbus, OH, ³The Ohio State University, Columbus, OH, ⁴The Ohio State University, Columbus Cancer Council, Hilliard, OH

7:20 PM

517 - Poster Session B

Surveillance Testing in Women Following a Diagnosis of Early-Stage Endometrial Cancer

J. D. Wright¹, A. Neugut², A. I. Tergas^1,2, S. N. Lewin¹, W. M. Burke¹, Y. S. Lu², T. J. Herzog¹ and D. Hershman²
¹Columbia University, New York, NY, ²Columbia University College of Physicians and Surgeons, New York, NY

7:40 PM

518 - Poster Session B

Missed opportunities: patterns of medical care and hospice utilization among ovarian cancer patients

A. J. Brown, C. C. L. Sun, L. S. Prescott, L. M. Ramondetta and D. C. Bodurka
The University of Texas MD Anderson Cancer Center, Houston, TX

8:00 PM

519 - Poster Session B

An afterthought: end-of-life care documentation among ovarian cancer patients

A. J. Brown, C. C. L. Sun, L. S. Prescott, L. M. Ramondetta and D. C. Bodurka
The University of Texas MD Anderson Cancer Center, Houston, TX

8:20 PM

520 - Poster Session B

The effect of treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma

J. Berger¹, E. M. Scott¹, P. Sukumvanich¹, A. L. Smith², J. T. Comerci¹, A. B. Olawaiye¹, J. L. Kelley III¹, S. Beriwal¹ and M. Huang¹
¹Magee-Womens Hospital of UPMC, Pittsburgh, PA, ²Geisinger Medical Center, Danville, PA

8:40 PM

521 - Poster Session B

Improved quality of life for early stage estrogen positive cancer survivors on a low carbohydrate, calorie restricted dietary intervention

L. A. Rojas-Espaillat^1,2,3, A. K. Krie², H. Demuth^1,2, K. N. Bohlen^1,2,3, Y. Hu^3,4, M. S. Fagerness^1,2, N. L. Flier^1,2, J. Kittelsrud^1,2, Z. M. Weber^4,5 and E. A. Ehli^3,4
¹Avera Research Institute, Sioux Falls, SD, ²Avera Cancer Institute, Sioux Falls, SD, ³University of South Dakota, Sioux Falls, SD, ⁴Avera Institute for Human Genetics, Sioux Falls, SD, ⁵University of South Dakota, Vermillion, SD

9:00 PM

522 - Poster Session B

Novel functions for LIN28A/B in ovarian cancer predisposition and tumorigenicity

M. L. Anderson¹, C. Mach², Z. Liu¹ and Y. W. Wan¹
¹Baylor College of Medicine, Houston, TX, ²University of Houston, Houston, TX

9:20 PM

523 - Poster Session B

Serine protease matriptase and CA-125 co-testing for ovarian cancer detection

R. L. Stone¹, A. F. Burnett¹, W. C. Hitt¹, K. Reynolds¹, K. O'Brien², J. B. Beard² and T. J. O'Brien³
¹University of Arkansas for Medical Sciences, Little Rock, AR, ²Stage I Diagnostics, Inc., Little Rock, AR, ³University of Arknasas for Medical Sciences, Little Rock, AR

9:40 PM

524 - Poster Session B

Prevalence of cognitive impairment, pain, depression, and neuropathy in women with gynecologic malignancies

N. S. Nevadunsky, G. Kaur, A. R. Van Arsdale, D. Y. S. Kuo, J. Y. Hou, J. Levitt, M. H. Einstein and G. L. Goldberg
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

10:00 PM

525 - Poster Session B

Correlation of survival-stratified proteomic and curated gene data reveal a three protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer

K. A. Byrd¹, N. W. Bateman², G. Wang², B. L. Hood², K. M. Darcy², C. Zahn³, C. A. Hamilton¹, J. M. Lancaster⁴, G. L. Maxwell⁵ and T. P. Conrads²
¹Walter Reed National Military Medical Center, Bethesda, MD, ²Gynecologic Cancer Center of Excellence, Annandale, VA, ³Uniformed Services University of the Health Sciences, Bethesda, MD, ⁴H. Lee Moffitt Cancer Center, Tampa, FL, ⁵Inova Fairfax Hospital, Falls Church, VA

10:20 PM

526 - Poster Session B

Diminished survival of separated, divorced, or widowed uterine cancer patients: a potential focus for survivorship programs

W. J. Lowery¹, M. P. Stany¹, N. T. Phippen¹, K. P. Bunch¹, C. Tian², G. L. Maxwell³, K. M. Darcy⁴ and C. A. Hamilton¹
¹Walter Reed National Military Medical Center, Bethesda, MD, ²Precision Therapeutics, Inc., Pittsburgh, PA, ³Inova Fairfax Hospital, Falls Church, VA, ⁴Gynecologic Cancer Center of Excellence, Annandale, VA

10:40 PM

527 - Poster Session B

Location of Hospice Referral and its Impact on Subsequent ED visits

S. A. Sullivan¹, J. E. Stine², K. M. Doll³, V. L. Bae-Jump⁴, L. Van Le², J. T. Soper⁵, P. A. Gehrig⁴ and K. H. Kim²
¹University of North Carolina, Chapel Hill, NC, ²University of North Carolina at Chapel Hill, Chapel Hill, NC, ³University of North Carolina at Chapel Hill, Chapel Hill, NC, Chapel Hill, NC, ⁴University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, ⁵University of North Carolina at Chapel HIll, Chapel Hill, NC

11:00 PM

528 - Poster Session B

BRCA mutation status is not associated with diminished ovarian reserve among women at high risk for ovarian cancer

L. L. Holman¹, B. Fellman¹, D. Urbauer¹, E. Kovanci², K. H. Lu¹ and T. L. Woodard^1,2
¹The University of Texas MD Anderson Cancer Center, Houston, TX, ²Baylor College of Medicine, Houston, TX

11:20 PM

529 - Poster Session B

Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery

L. M. Bean, K. K. Ward, N. R. Shah, M. A. Davis, C. C. Saenz, S. C. Plaxe and M. T. McHale
UCSD Rebecca and John Moores Cancer Center, La Jolla, CA

11:40 PM

530 - Poster Session B

A pilot study of depression prevalence and progression in patients receiving chemotherapy for gynecologic malignancies using a validated tool

A. M. Wilkinson¹, B. A. Mahar², T. Gerber³ and P. F. Timmins III¹
¹Women's Cancer Care Associates, Albany, NY, ²Women's Cancer Care Associates, LLC, Albany, NY, ³Capital District Physicians Health Plan (CDPHP), Albany, NY

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

Poster Session B